Show simple item record

dc.contributor.authorCarranza Naval, María José 
dc.contributor.authorVargas Soria, María 
dc.contributor.authorHierro Bujalance, Carmen
dc.contributor.authorBaena Nieto, María Gloria 
dc.contributor.authorGarcía Alloza, Mónica 
dc.contributor.authorInfante-Garcia, Carmen
dc.contributor.authorMarco Delgado, Ángel José del 
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.date.accessioned2021-04-15T10:24:43Z
dc.date.available2021-04-15T10:24:43Z
dc.date.issued2021-02
dc.identifier.issn2218-273X
dc.identifier.urihttp://hdl.handle.net/10498/24704
dc.description.abstractAlzheimer's disease (AD) is the most common cause of dementia. Epidemiological studies show the association between AD and type 2 diabetes (T2DM), although the mechanisms are not fully understood. Dietary habits and lifestyle, that are risk factors in both diseases, strongly modulate gut microbiota composition. Also, the brain-gut axis plays a relevant role in AD, diabetes and inflammation, through products of bacterial metabolism, like short-chain fatty acids. We provide a comprehensive review of current literature on the relation between dysbiosis, altered inflammatory cytokines profile and microglia in preclinical models of AD, T2DM and models that reproduce both diseases as commonly observed in the clinic. Increased proinflammatory cytokines, such as IL-1 beta and TNF-alpha, are widely detected. Microbiome analysis shows alterations in Actinobacteria, Bacteroidetes or Firmicutes phyla, among others. Altered alpha- and beta-diversity is observed in mice depending on genotype, gender and age; therefore, alterations in bacteria taxa highly depend on the models and approaches. We also review the use of pre- and probiotic supplements, that by favoring a healthy microbiome ameliorate AD and T2DM pathologies. Whereas extensive studies have been carried out, further research would be necessary to fully understand the relation between diet, microbiome and inflammation in AD and T2DM.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceBiomolecules 2021, 11(2), 262es_ES
dc.subjectAlzheimer's diseasees_ES
dc.subjecttype 2 diabetes mellituses_ES
dc.subjectmicrobiotaes_ES
dc.subjectdietes_ES
dc.subjectmicrogliaes_ES
dc.subjectinflammationes_ES
dc.titleAlzheimer's Disease and Diabetes: Role of Diet, Microbiota and Inflammation in Preclinical Modelses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/biom11020262
dc.relation.projectIDPrograma Estatal de I+D+I orientada a los Retos de la Sociedad - Agencia Estatal de Investigacion (AEI) [BFU 2016-75038R]es_ES
dc.relation.projectIDFondo Europeo de Desarrollo Regional (FEDER). Comisión Europea [PI-0008-2017]es_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This work is under a Creative Commons License Atribución 4.0 Internacional